2025-07-09 08:40Key Highlights The company anticipates a significant increase in net profit attributable to shareholders for the first half of 2025 2025 First Half Performance Forecast Overview | Metric | Amount (RMB) | Change | Year-on-Year Growth | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders (Estimated) | 4.45 billion | Increased by 1.508 billion | Approx. 52% | Current Period Performance Forecast This section details the company's financial performance forecast for the first half of 2025, including the reporting period and key profit estimates Performance Forecast Period The performance forecast covers the financial period from January 1, 2025, to June 30, 2025 - The performance forecast period is from January 1, 2025, to June 30, 20253 Performance Forecast Details The company expects net profit attributable to shareholders for the first half of 2025 to reach 4.45 billion RMB, representing an approximate 52% year-on-year increase 2025 First Half Net Profit Attributable to Shareholders Forecast | Metric | Amount (RMB) | Change | Year-on-Year Growth | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders (Estimated) | 4.45 billion | Increased by 1.508 billion | Approx. 52% | Unaudited Statement The financial data disclosed in this performance forecast is a preliminary estimate by the company's finance department and has not been audited by a certified public accountant - The data in this performance forecast has not been audited by a certified public accountant3 Prior Period Operating Performance and Financial Status This section provides an overview of the company's operating performance and financial status for the same period in the previous year Prior Period Net Profit Attributable to Shareholders Net profit attributable to shareholders for the prior period (first half of 2024) was 2.942 billion RMB Prior Period Net Profit Attributable to Shareholders | Metric | Amount (RMB) | | :--- | :--- | | Net Profit Attributable to Shareholders | 2.942 billion | Prior Period Earnings Per Share Earnings per share for the prior period (first half of 2024) was 0.79 RMB Prior Period Earnings Per Share | Metric | Amount (RMB) | | :--- | :--- | | Earnings Per Share | 0.79 | Main Reasons for Performance Increase The primary driver for the anticipated performance increase is the change in accounting treatment following the acquisition of an additional stake in Shanghai Hutchison Pharmaceuticals - The company completed the acquisition of an additional 10% equity stake in Shanghai Hutchison Pharmaceuticals Co., Ltd. on April 25, 2025, increasing its total holding to 60% from 50%56 - Hutchison Pharmaceuticals' accounting method changed from equity method for a joint venture to consolidation as a subsidiary, bringing it into the consolidated financial statements6 - According to accounting standards, the re-measurement of previously held equity at fair value upon gaining control due to additional investment, with the difference between fair value and book value recognized as investment income in the current period, is the main reason for the performance increase6 Risk Warning This section highlights that the performance forecast data is preliminary and unaudited, with no major uncertainties identified as of the disclosure date - The data in this performance forecast is a preliminary estimate by the finance department and has not been audited by an accounting firm7 - As of the disclosure date, the company has not identified any significant uncertainties affecting the accuracy of this performance forecast7 Other Explanatory Matters Investors are advised to exercise caution as the forecast data is preliminary, and the final accurate financial figures will be based on the official 2025 semi-annual report - The forecast data is preliminary, and the specific accurate financial data will be subject to the company's officially disclosed 2025 semi-annual report8 - Investors are reminded to make prudent decisions and be aware of investment risks8